Eli Lilly (NY:LLY)

1,142.85 -7.00 (-0.61%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

$100 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today ↗

July 01, 2026

Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 7.2% on an annualized basis producing an average annual return of 16.46%. Currently, Eli Lilly has a market capitalization of...

Via Benzinga

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Via GlobeNewswire

Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks

June 30, 2026

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Phibro Animal Hea...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest

June 30, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Zoetis (NYSE:ZTS) and its pee...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Why Illumina (ILMN) Stock Is Down Today

June 30, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge...

Via StockStory

Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness ↗

June 30, 2026

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.

Via Benzinga

3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗

June 30, 2026

All three ETFs complement each other well in a portfolio.

Via The Motley Fool

Topics ETFs Stocks

Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow ↗

June 30, 2026

Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a handful of bargains and pretenders.

Via The Motley Fool

Topics Artificial Intelligence Stocks

5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX ↗

June 30, 2026

SpaceX recently completed a record IPO.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years ↗

June 30, 2026

The weight loss tailwind isn't about to come to a halt.

Via The Motley Fool

Big Pharma Has a Case of Merger Mania ↗

June 30, 2026

Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

Via The Motley Fool

Topics Intellectual Property

5 Places Investors Can Hide If the AI Trade Keeps Cracking ↗

June 29, 2026

As AI stocks face volatility, capital is rotating into biotech, industrials, utilities, consumer staples, and dividend ETFs showing relative strength.

Via MarketBeat

Topics Artificial Intelligence ETFs

3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More ↗

June 29, 2026

Why settle for puny yields when you can buy these monster dividend stocks?

Via The Motley Fool

Topics ETFs Energy

2 Top Growth Stocks to Buy Right Now Without Hesitation ↗

June 29, 2026

These stocks are no-brainer buys.

Via The Motley Fool

Topics Economy

Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗

June 29, 2026

These stocks are better bets to skyrocket than the much-hyped rocket stock.

Via The Motley Fool

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now ↗

June 27, 2026

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates ↗

June 27, 2026

The top stocks are showing relative strength. Two are defensive growth plays.

Via Investor's Business Daily

Revealed! 3 Undervalued Stocks I Just Bought ↗

June 26, 2026

There are still great opportunities in an otherwise volatile market.

Via The Motley Fool

Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy? ↗

June 26, 2026

Eli Lilly holds a dominant market share in the weight loss treatment category.

Via The Motley Fool

Why Eli Lilly Stock Jumped to a New All-Time High Today ↗

June 26, 2026

The pharma titan is expanding into new markets.

Via The Motley Fool

Lilly Hits Record High Amid Massive Profit Growth, Leads 28 Just Added To Best Stock Lists ↗

June 26, 2026

Eli Lilly is a leader in the revolutionary GLP weight-loss market. Lilly was one of 28 stocks new to best stock lists Friday.

Via Investor's Business Daily

Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly? ↗

June 26, 2026

Novo Nordisk offers dividend income and MASH upside versus Lilly's high‑growth obesity lead.

Via The Motley Fool

Discover which S&P500 stocks are making waves on Friday. ↗

June 26, 2026

Via Chartmill

Why Is Eli Lilly (LLY) Stock Soaring Today

June 26, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European Medicines Agency's commit...

Via StockStory

Snap’s Specs Gamble ↗

June 26, 2026

The smartphone could be a thing of the past if Snap has its way. But at $2,195, it could be a tall order to sell Specs to consumers, even if they were stylish.

Via The Motley Fool

Topics Workforce

Friday's session: top gainers and losers in the S&P500 index ↗

June 26, 2026

Via Chartmill

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? ↗

June 26, 2026

Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.

Via The Motley Fool

Topics ETFs

2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying ↗

June 26, 2026

These aren't for the faint of heart.

Via The Motley Fool

Topics Artificial Intelligence

An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right? ↗

June 25, 2026

Novo Nordisk is no longer the front-runner, but it's not out of the running, either.

Via The Motley Fool

Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success ↗

June 25, 2026

ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concurrent share purchase.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.